2021
Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
ZÁVACKÁ, Kristýna a Karla PLEVOVÁZákladní údaje
Originální název
Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
Autoři
ZÁVACKÁ, Kristýna (203 Česká republika, domácí) a Karla PLEVOVÁ (203 Česká republika, garant, domácí)
Vydání
Frontiers in Oncology, Lausanne, Frontiers Media S.A. 2021, 2234-943X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.738
Kód RIV
RIV/00216224:14110/21:00120226
Organizační jednotka
Lékařská fakulta
UT WoS
000729014900001
Klíčová slova anglicky
chromothripsis; chronic lymphocytic leukemia; complex chromosomal rearrangements; copy number alterations; genomic array; paired-end sequencing; oncogene amplification; tumor suppressor inactivation
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 8. 2. 2022 14:03, Mgr. Tereza Miškechová
Anotace
V originále
Chromothripsis represents a mechanism of massive chromosome shattering and reassembly leading to the formation of derivative chromosomes with abnormal functions and expression. It has been observed in many cancer types, importantly, including chronic lymphocytic leukemia (CLL). Due to the associated chromosomal rearrangements, it has a significant impact on the pathophysiology of the disease. Recent studies have suggested that chromothripsis may be more common than initially inferred, especially in CLL cases with adverse clinical outcome. Here, we review the main features of chromothripsis, the challenges of its assessment, and the potential benefit of its detection. We summarize recent findings of chromothripsis occurrence across hematological malignancies and address its causes and consequences in the context of CLL clinical features, as well as chromothripsis-related molecular abnormalities described in published CLL studies. Furthermore, we discuss the use of the current knowledge about genome functions associated with chromothripsis in the optimization of treatment strategies in CLL.
Návaznosti
EF16_026/0008448, projekt VaV |
| ||
MUNI/A/1595/2020, interní kód MU |
| ||
MUNI/IGA/1640/2020, interní kód MU |
| ||
NU21-08-00237, projekt VaV |
|